{"id":58188,"date":"2023-10-06T12:35:52","date_gmt":"2023-10-06T15:35:52","guid":{"rendered":"https:\/\/www.colfarma.info\/colfarma\/?p=58188"},"modified":"2023-11-28T09:03:36","modified_gmt":"2023-11-28T12:03:36","slug":"la-rpvf-aconseja-no-usar-topiramato-durante-el-embarazo","status":"publish","type":"post","link":"https:\/\/www.colfarma.info\/colfarma\/la-rpvf-aconseja-no-usar-topiramato-durante-el-embarazo\/","title":{"rendered":"La RPVF aconseja no usar topiramato durante el embarazo"},"content":{"rendered":"<p>La RPVF recomend\u00f3 no utilizar topiramato durante el embarazo si hay otro tratamiento alternativo, citando datos recientes que sugieren un posible mayor riesgo de trastornos del neurodesarrollo, incluidos trastornos del espectro autista, discapacidad intelectual y trastorno por d\u00e9ficit de atenci\u00f3n con hiperactividad.<\/p>\n<p>As\u00ed, en mujeres embarazadas no se debe utilizar topiramato para el tratamiento de la epilepsia a no ser que no exista otra alternativa terap\u00e9utica. El topiramato para la profilaxis de la migra\u00f1a ya est\u00e1 contraindicado durante el embarazo.<\/p>\n<p>Adem\u00e1s, se hace hincapi\u00e9 en la importancia de que las mujeres en edad f\u00e9rtil utilicen m\u00e9todos anticonceptivos altamente eficaces o combinen dos m\u00e9todos complementarios durante el tratamiento con topiramato.<\/p>\n<p><a href=\"https:\/\/www.colfarma.info\/colfarma\/wp-content\/uploads\/REPORTE-261.pdf\">https:\/\/www.colfarma.info\/colfarma\/wp-content\/uploads\/REPORTE-261.pdf<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La RPVF recomend\u00f3 no utilizar topiramato durante el embarazo si hay otro tratamiento alternativo, citando datos recientes que sugieren un posible mayor riesgo de trastornos del neurodesarrollo, incluidos trastornos del espectro autista, discapacidad intelectual y trastorno por d\u00e9ficit de atenci\u00f3n con hiperactividad. As\u00ed, en mujeres embarazadas no se debe utilizar topiramato para el tratamiento de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":58189,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1163],"tags":[],"class_list":["post-58188","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cimf-recomienda"],"_links":{"self":[{"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/posts\/58188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/comments?post=58188"}],"version-history":[{"count":0,"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/posts\/58188\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/media\/58189"}],"wp:attachment":[{"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/media?parent=58188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/categories?post=58188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.colfarma.info\/colfarma\/wp-json\/wp\/v2\/tags?post=58188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}